1 vs 7 RATG Infusions in Renal Transplantation
Conditions: Kidney Replacement Interventions: Drug: RATG; Drug: Basiliximab Sponsors: Mario Negri Institute for Pharmacological Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy
Conditions: Diabetic Foot; Diabetic Neuropathies; Diabetic Foot Ulcer Interventions: Biological: Transplantation of Placenta Derived Stem Cells Sponsors: Michael H Carstens; Ministerio de Salud de Nicaragua; Wake Forest Institute for Regenerative Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
Conditions: Acute Myeloid Leukemia Interventions: Drug: Oral Azacitidine Sponsors: Virginia Commonwealth University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Inspiratory Muscle Training in Lung Transplant Candidates
Conditions: Inspiratory Muscle Training Interventions: Other: IMT and exercise training group Sponsors: University Health Network, Toronto; Canadian National Transplant Research Program; Canadian Institutes of Health Research (CIHR); Ozmosis Research Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Washed Microbiota Transplantation for Allergic Rhinitis
Conditions: Rhinitis, Allergic Interventions: Drug: Washed Microbiota Transplantation; Drug: Placebo Sponsors: The Second Hospital of Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
Conditions: Recurrent Clostridioides Difficile Infection; Colonic Surgery Interventions: Drug: IMT; Other: Saline solution Sponsors: University of Minnesota Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Immunometabolism of Machine Perfusion Strategies
Conditions: Liver Transplantation Interventions: Device: Machine Perfusion Sponsors: King ' s College Hospital NHS Trust; King ' s College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Transplant Wellness Program
Conditions: Transplantation Interventions: Behavioral: Transplant Wellness Program - Kidney and Liver Sponsors: University of Calgary Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations
Conditions: Delayed Graft Function; End Stage Renal Disease; Kidney Transplantation Interventions: Drug: Goal-Directed Fluid Therapy (GDFT); Drug: Regular Fluid Therapy Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma
Conditions: Lymphopenia Sponsors: Chang Gung Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment
Conditions: Hepatic Encephalopathy; Dysbiosis Interventions: Procedure: Fecal microbiota transplantation delivery through colonoscopy; Drug: Fecal microbiota transplantation delivery through oral capsules Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial
DiscussionThe BOPPP trial aims to investigate the clinical and cost-effectiveness of carvedilol in patients with cirrhosis and small oesophageal varices to determine whether this non-selective beta-blocker can prevent or reduce hepatic decompensation. There is clinical equipoise on whether intervening in cirrhosis, at an earlier stage of portal hypertension, with NSBB therapy is beneficial. Should the trial yield a positive result, we anticipate that the administration and use of carvedilol will become widespread with pathways developed to standardise the administration of the medication in primary care.Ethics and dissemin...
Source: Trials - April 16, 2024 Category: Research Source Type: clinical trials
Use of Wearables to Detect Infections in Kidney Transplant Recipients
Conditions: Kidney Transplant Infection Sponsors: Institute for Clinical and Experimental Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
GEnomic Medicine in Kidney Transplantation Study
Conditions: Transplant Complication; Kidney Transplant Rejection Interventions: Diagnostic Test: Biomarker discovery and validation - with focus on genomic biomarkers Sponsors: Western Sydney Local Health District Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
Conditions: B-NHL, Extranodal, TP53 Alterations, Bulky Mass Interventions: Biological: autologous stem-cell transplantation, Relmacabtagene autoleucel (relma-cel) Sponsors: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
